Volume 6, Issue 2
Bulletin Boardp. 191
Bulletin Board: Volume-6, Issue-2
Appendicesp. 289
ACKNOWLEDGEMENTS: Volume 6 Issue 2
Appendicesp. 290
AUTHOR GUIDELINES: Volume 6 Issue 2
Appendicesp. 284
Glossary: Volume 6 Issue 2
Appendicesp. 286
Indices: Volume 6 Issue 2
Conference Proceedingp. 279
Briefings from ACAAI 2008 Annual meeting
Author(s): Desiree Larenas-Linnemann
Review Articlep. 259
Alzheimers disease: from pathogenesis to novel therapeutic approaches
Author(s): Elio Scarpini and Daniela Galimberti
Review Article
Motor side effects of atypical antipsychotic drugs
Author(s): Victoria Chang and Joseph H Friedman
Drug Evaluationp. 239
Capecitabine in colorectal cancer
Author(s): Michael S Braun and Chris J Twelves
Drug Evaluationp. 231
Mepolizumab in the treatment of eosinophilic esophagitis
Author(s): Rana F Ammoury and Sandeep K Gupta
Drug Evaluationp. 209
Insulin glulisine: preclinical hallmarks and clinical efficacy
Author(s): Freimut Schliess and Tim Heise
Drug Evaluationp. 199
Liraglutide: a human GLP-1 analog for Type 2 diabetes
Author(s): Tina Vilsboll
Forewordp. 131
Neurogenic bladder: current and future treatment strategies
Author(s): Jeffrey S Palmer
Editorialp. 187
Rivaroxaban, a new oral factor Xa inhibitor, provides new data on anticoagulation
Author(s): Aurangzeb Siddique, Gregory YH Lip and Eduard Shantsila
Review Articlep. 177
Regenerative medicine strategies for treatment of neurogenic bladder
Author(s): Roberto Soler, Claudius Fullhase and Anthony Atala
Review Articlep. 165
Botulinum toxin: historical perspective and treatment of neurogenic and idiopathic overactive bladder
Author(s): Daniel Mulligan and Raymond Bologna
Review Articlep. 157
Surgical and nonsurgical treatment options for pediatric neurogenic bladder
Author(s): Boris Chertin, Jacob Golomb and Yoram Mor
Review Articlep. 151
Anatomy of urinary continence and neurogenic incontinence
Author(s): Jacob Golomb, Boris Chertin and Yoram Mor1
Review Articlep. 145
Application and comparison of the AUA and EAU current recommendations for antibiotic prophylaxis in the urologic patient undergoing office procedures
Author(s): Morgan Koepke, Jeffrey Cerone and Raymond Bologna
Research Highlightsp. 143
Highlights from the latest articles in the treatment of neurogenic bladder
Author(s): Michael Ingber and Sandip Vasavada
Interviewp. 139
Current and future treatment of neurogenic bladder
Author(s): Howard B Goldman
News and Viewsp. 135
News & Views in Targeted anticancer therapy
Editorialp. 133
Two popular treatment options for neurogenic bladder
Author(s): Raymond Bologna, Jeffrey S Palmer
